GSK-3 beta (NT) Polyclonal Antibody, PE-Cy5 Conjugated
Cat# bs-0023M-PE-Cy5
Size : 100ul
Brand : Bioss
GSK-3 beta (NT) Polyclonal Antibody, PE-Cy5 Conjugated
Applications
Reactivity
Predicted Reactivity
| Overview | |
| Catalog # | bs-0023M-PE-Cy5 |
| Product Name | GSK-3 beta (NT) Polyclonal Antibody, PE-Cy5 Conjugated |
| Applications | WB |
| Reactivity | Human, Mouse, Zebrafish |
| Predicted Reactivity | Rat, Dog, Cow, Sheep, Pig, Horse, Chicken |
| Specifications | |
| Conjugation | PE-Cy5 |
| Host | Mouse |
| Source | KLH conjugated synthetic peptide derived from human GSK-3 Beta |
| Immunogen Range | 1-50/420 |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 2932 |
| Swiss Prot | P49841 |
| Subcellular location | Cytoplasm, Nucleus, Cell membrane |
| Synonyms | Glycogen synthase kinase-3 beta; GSK-3 beta; Serine/threonine-protein kinase GSK3B; GSK3B |
| Background | The protein encoded by this gene is a serine-threonine kinase, belonging to the glycogen synthase kinase subfamily. It is involved in energy metabolism, neuronal cell development, and body pattern formation. Polymorphisms in this gene have been implicated in modifying risk of Parkinson disease, and studies in mice show that overexpression of this gene may be relevant to the pathogenesis of Alzheimer disease. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009] |
| Application Dilution | |
| WB | 1:300-5000 |